1. Management of sepsis;Russell;N Engl J Med,2006
2. Efficacy and safety of recombinant human activated protein C for severe sepsis;Bernard;N Engl J Med,2001
3. Drotrecogin alfa (activated) in children with severe sepsis;Nadel;a multicentre phase III randomised controlled trial,2007
4. Extended evaluation of recombinant human activated protein C United States Trial (ENHANCE US);Bernard;a single-arm, phase 3B, multicenter study of drotrecogin alfa (activated) in severe sepsis,2004
5. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death;Abraham;N Engl J Med,2005